Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies.
Saved in:
| Title: | Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studies. |
|---|---|
| Authors: | Toi, M.1,2 toi@kuhp.kyoto-u.ac.jp, Iwata, H.3, Fujiwara, Y.4, Ito, Y.5, Nakamura, S.6, Tokuda, Y.7, Taguchi, T.8, Rai, Y.9, Aogi, K.10, Arai, T.11, Watanabe, J.12, Wakamatsu, T.13, Katsura, K.13, Ellis, C. E.14, Gagnon, R. C.14, Allen, K. E.14, Sasaki, Y.15, Takashima, S.10 |
| Source: | British Journal of Cancer. 11/17/2009, Vol. 101 Issue 10, p1676-1682. 7p. 4 Charts, 3 Graphs. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
